애완동물용 광요법 기기 시장 규모, 점유율 및 동향 분석 보고서 : 기술별, 애완동물별, 제품별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Pet Light Therapy Devices Market Summary

The global pet light therapy devices market size was estimated at USD 67.5 million in 2025 and is projected to reach USD 148.5 million by 2033, growing at a CAGR of 10.6% from 2026 to 2033. The market is advancing due to increasing demand for red light therapy devices for pets, rising technological advancements in pet therapy devices, and growing adoption of at-home pet rehabilitation devices.

The expanding global pet population is a significant market driver. As of 2025, global pet ownership has surpassed one billion animals, with over 900 million pet dogs and 370 million pet cats recorded worldwide. According to a report, in the U.S., approximately 66% of households, which is 86.9 million homes, owned at least one pet as of 2025. This population scale directly translates into a sizable addressable patient base for therapeutic veterinary devices. Similarly, pet humanization is accelerating owner willingness to pursue non-invasive, drug-free treatment modalities. Photobiomodulation therapy, which operates through red and near-infrared wavelengths typically ranging from 600 nm to 1,000+ nm, has gained momentum as a clinically relevant intervention for musculoskeletal conditions, chronic pain, and wound healing in companion animals. These are high-prevalence conditions across aging dog and cat populations, where osteoarthritis, cruciate ligament injuries, intervertebral disc disease, and post-surgical inflammation represent recurring therapeutic indications.

In addition, rapid innovation in device engineering is materially expanding the functional scope and commercial addressability of the market. Manufacturers are transitioning from single-modality, single-wavelength systems to multi-wavelength platforms capable of delivering targeted therapeutic outputs across distinct tissue depths. This multi-spectral capability enables a single device to address a broader set of clinical indications, improving per-unit utility for both veterinary clinics and home users. In addition, wearable formats represent a particularly significant product innovation. LED-integrated wraps, coats, and straps allow continuous, hands-free therapy delivery, improving treatment compliance in animals that resist stationary or handheld device protocols. For instance, the HEALED LED Wrap, engineered specifically for canine pain management, employs clinically validated red and near-infrared wavelengths to reduce inflammatory markers and inhibit peripheral nerve conduction, targeting conditions including arthritis, cruciate ligament injury, post-operative pain, and neuropathic pain without requiring clinical oversight during each session.

In addition, the shift toward home-based pet rehabilitation is generating sustained demand for consumer-facing light therapy devices. Pet owners are increasingly seeking alternatives to frequent, high-cost veterinary clinic visits, particularly for chronic conditions requiring ongoing therapeutic management. Light therapy, delivered through LED-based handheld devices and therapy mats, offers a cost-effective and operationally accessible modality for maintaining treatment continuity between clinical sessions.

Moreover, LED devices have accelerated in the home-use segment due to their safety profile relative to laser systems. LED devices use non-coherent, broad-spectrum light that reduces tissue damage risk and does not require specialized handling training. This distinction makes LED technology practically suitable for unsupervised home administration by pet owners, supporting daily or multi-session protocols for conditions such as joint stiffness, chronic arthritis, and superficial wound healing.

In addition, the expansion of pet insurance coverage is supporting at-home device adoption. In the U.S., approximately 6.4 million pets were insured as of 2024, representing nearly 10% of the national pet population, with total insurance premiums reaching USD 4.7 billion by year-end 2024. Growing financial coverage for pet healthcare creates greater spending capacity among owners for supplementary therapeutic devices. For instance, established at-home platforms such as LumaSoothe 2, offering dual treatment modes for joint and skin conditions, respectively, illustrate the commercial viability of this segment, as LED devices increasingly function as routine home-care complements to professional veterinary treatment rather than standalone clinical substitutes.

Global Pet Light Therapy Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pet light therapy devices market report based on product, technology, pet, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Devices
  • Benchtop Device
  • Handheld Device
• Wearable Coats & Straps
• Light Therapy Mats
• Consumables/ Accessories
• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Lasers
  • Cold Lasers
  • Hot Lasers
• LEDs
• Pet Outlook (Revenue, USD Million, 2021 - 2033)
• Dogs
• Cats
• Horses
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Pain Management
• Wound Healing
• Dermatology
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Veterinary Clinics & Hospitals
• Pet Owners
• Others
• Region Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
  • Qatar
  • Oman

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Technology
  • 1.2.3. Pet
  • 1.2.4. Application
  • 1.2.5. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information/Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Model 1: Commodity Flow Analysis
  • 1.7.2. Model 2: Bottom-Up Analysis
  • 1.7.3. Model 3 Volume-Pricing Analysis
• 1.8. List of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary/Related Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Demand for Red Light Therapy Devices for Pets
    • 3.2.1.2. Rising Technological Advancements in Pet Therapy Devices
    • 3.2.1.3. Growing Adoption of At-Home Pet Rehabilitation Devices
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Cost of Advanced Light Therapy Devices
    • 3.2.2.2. Limited Clinical Awareness and Standardization
  • 3.2.3. Market Opportunity Analysis
• 3.3. Estimated Animal Population by Key Species & Key Countries, 2025
• 3.4. Market Analysis Tools
  • 3.4.1. Porter's Five Forces Analysis
  • 3.4.2. PESTEL by SWOT Analysis

Chapter 4. Pet Light Therapy Devices Market: By Product Estimates & Trend Analysis

• 4.1. Pet Light Therapy Devices Market, By Product: Segment Dashboard
• 4.2. Pet Light Therapy Devices Market, By Product Movement Analysis
• 4.3. Pet Light Therapy Devices Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
• 4.4. Devices
  • 4.4.1. Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Benchtop Device
    • 4.4.2.1. Benchtop Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Handheld Device
    • 4.4.3.1. Handheld Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Wearable Coats & Straps
  • 4.5.1. Wearable Coats & Straps Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Light Therapy Mats
  • 4.6.1. Light Therapy Mats Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Consumables/Accessories
  • 4.7.1. Consumables/Accessories Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Pet Light Therapy Devices Market: By Technology Estimates & Trend Analysis

• 5.1. Pet Light Therapy Devices Market, By Technology: Segment Dashboard
• 5.2. Pet Light Therapy Devices Market, By Technology Movement Analysis
• 5.3. Pet Light Therapy Devices Market Estimates & Forecasts, by Technology, 2021 to 2033 (USD Million)
• 5.4. Lasers
  • 5.4.1. Lasers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.2. Cold Lasers
    • 5.4.2.1. Cold Lasers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4.3. Hot Lasers
    • 5.4.3.1. Hot Lasers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. LEDs
  • 5.5.1. LEDs Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Pet Light Therapy Devices Market: By Pet Estimates & Trend Analysis

• 6.1. Pet Light Therapy Devices Market, By Pet: Segment Dashboard
• 6.2. Pet Light Therapy Devices Market, By Pet Movement Analysis
• 6.3. Pet Light Therapy Devices Market Estimates & Forecasts, by Pet, 2021 to 2033 (USD Million)
• 6.4. Dogs
  • 6.4.1. Dogs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Cats
  • 6.5.1. Cats Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Horses
  • 6.6.1. Horses Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Pet Light Therapy Devices Market: By Application Estimates & Trend Analysis

• 7.1. Pet Light Therapy Devices Market, By Application: Segment Dashboard
• 7.2. Pet Light Therapy Devices Market, By Application Movement Analysis
• 7.3. Pet Light Therapy Devices Market Estimates & Forecasts, by Application, 2021 to 2033 (USD Million)
• 7.4. Pain Management
  • 7.4.1. Pain Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Wound Healing
  • 7.5.1. Wound Healing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Dermatology
  • 7.6.1. Dermatology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Others
  • 7.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Pet Light Therapy Devices Market: By End Use Estimates & Trend Analysis

• 8.1. Pet Light Therapy Devices Market, By End Use: Segment Dashboard
• 8.2. Pet Light Therapy Devices Market, By End Use Movement Analysis
• 8.3. Pet Light Therapy Devices Market Estimates & Forecasts, by End Use, 2021 to 2033 (USD Million)
• 8.4. Veterinary Clinics & Hospitals
  • 8.4.1. Veterinary Clinics & Hospitals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Pet Owners
  • 8.5.1. Pet Owners Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.6. Others
  • 8.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Pet Light Therapy Devices Market: By Regional Estimates & Trend Analysis

• 9.1. Region Market Dashboard
• 9.2. Region Market Share Analysis, 2025 & 2033
• 9.3. North America
  • 9.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.2. U.S
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. Competitive Scenario
    • 9.3.2.3. Regulatory Framework
    • 9.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Competitive Scenario
    • 9.3.3.3. Regulatory Framework
    • 9.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.3.4. Mexico
    • 9.3.4.1. Key Country Dynamics
    • 9.3.4.2. Competitive Scenario
    • 9.3.4.3. Regulatory Framework
    • 9.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.4. Europe
  • 9.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.2. UK
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Competitive Scenario
    • 9.4.2.3. Regulatory Framework
    • 9.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.3. Germany
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Competitive Scenario
    • 9.4.3.3. Regulatory Framework
    • 9.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.4. France
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Competitive Scenario
    • 9.4.4.3. Regulatory Framework
    • 9.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.5. Italy
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Competitive Scenario
    • 9.4.5.3. Regulatory Framework
    • 9.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.6. Spain
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Competitive Scenario
    • 9.4.6.3. Regulatory Framework
    • 9.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.7. Denmark
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Competitive Scenario
    • 9.4.7.3. Regulatory Framework
    • 9.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.8. Sweden
    • 9.4.8.1. Key Country Dynamics
    • 9.4.8.2. Competitive Scenario
    • 9.4.8.3. Regulatory Framework
    • 9.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.4.9. Norway
    • 9.4.9.1. Key Country Dynamics
    • 9.4.9.2. Competitive Scenario
    • 9.4.9.3. Regulatory Framework
    • 9.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.2. Japan
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Competitive Scenario
    • 9.5.2.3. Regulatory Framework
    • 9.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.3. China
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Competitive Scenario
    • 9.5.3.3. Regulatory Framework
    • 9.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.4. India
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Competitive Scenario
    • 9.5.4.3. Regulatory Framework
    • 9.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.5. Australia
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Competitive Scenario
    • 9.5.5.3. Regulatory Framework
    • 9.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.6. Thailand
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Competitive Scenario
    • 9.5.6.3. Regulatory Framework
    • 9.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5.7. South Korea
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Competitive Scenario
    • 9.5.7.3. Regulatory Framework
    • 9.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.6. Latin America
  • 9.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.2. Brazil
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Competitive Scenario
    • 9.6.2.3. Regulatory Framework
    • 9.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6.3. Argentina
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Competitive Scenario
    • 9.6.3.3. Regulatory Framework
    • 9.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.7. MEA
  • 9.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.2. South Africa
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Competitive Scenario
    • 9.7.2.3. Regulatory Framework
    • 9.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.3. UAE
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Competitive Scenario
    • 9.7.3.3. Regulatory Framework
    • 9.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.4. Saudi Arabia
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. Competitive Scenario
    • 9.7.4.3. Regulatory Framework
    • 9.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Competitive Scenario
    • 9.7.5.3. Regulatory Framework
    • 9.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.6. Qatar
    • 9.7.6.1. Key Country Dynamics
    • 9.7.6.2. Competitive Scenario
    • 9.7.6.3. Regulatory Framework
    • 9.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7.7. Oman
    • 9.7.7.1. Key Country Dynamics
    • 9.7.7.2. Competitive Scenario
    • 9.7.7.3. Regulatory Framework
    • 9.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Market Participant Categorization
  • 10.1.1. Market Leaders
  • 10.1.2. Emerging Players
• 10.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
• 10.3. Company Profiles
  • 10.3.1. Multi Radiance Medical
    • 10.3.1.1. Participant's Overview
    • 10.3.1.2. Financial Performance
    • 10.3.1.3. Product/Service Benchmarking
    • 10.3.1.4. Strategic Initiatives
  • 10.3.2. Envois (Companion Animal Health)
    • 10.3.2.1. Participant's Overview
    • 10.3.2.2. Financial Performance
    • 10.3.2.3. Product/Service Benchmarking
    • 10.3.2.4. Strategic Initiatives
  • 10.3.3. Respond Animal Therapeutics
    • 10.3.3.1. Participant's Overview
    • 10.3.3.2. Financial Performance
    • 10.3.3.3. Product/Service Benchmarking
    • 10.3.3.4. Strategic Initiatives
  • 10.3.4. Ailucs
    • 10.3.4.1. Participant's Overview
    • 10.3.4.2. Financial Performance
    • 10.3.4.3. Product/Service Benchmarking
    • 10.3.4.4. Strategic Initiatives
  • 10.3.5. Vaymed
    • 10.3.5.1. Participant's Overview
    • 10.3.5.2. Financial Performance
    • 10.3.5.3. Product/Service Benchmarking
    • 10.3.5.4. Strategic Initiatives
  • 10.3.6. PetThera
    • 10.3.6.1. Participant's Overview
    • 10.3.6.2. Financial Performance
    • 10.3.6.3. Product/Service Benchmarking
    • 10.3.6.4. Strategic Initiatives
  • 10.3.7. MedcoVet
    • 10.3.7.1. Participant's Overview
    • 10.3.7.2. Financial Performance
    • 10.3.7.3. Product/Service Benchmarking
    • 10.3.7.4. Strategic Initiatives
  • 10.3.8. Helio Pet
    • 10.3.8.1. Participant's Overview
    • 10.3.8.2. Financial Performance
    • 10.3.8.3. Product/Service Benchmarking
    • 10.3.8.4. Strategic Initiatives
  • 10.3.9. Lumera
    • 10.3.9.1. Participant's Overview
    • 10.3.9.2. Financial Performance
    • 10.3.9.3. Product/Service Benchmarking
    • 10.3.9.4. Strategic Initiatives
  • 10.3.10. Dog Med Laser
    • 10.3.10.1. Participant's Overview
    • 10.3.10.2. Financial Performance
    • 10.3.10.3. Product/Service Benchmarking
    • 10.3.10.4. Strategic Initiatives
  • 10.3.11. Dundies Pty Ltd.
    • 10.3.11.1. Participant's Overview
    • 10.3.11.2. Financial Performance
    • 10.3.11.3. Product/Service Benchmarking
    • 10.3.11.4. Strategic Initiatives
  • 10.3.12. Biophotas (celluma)
    • 10.3.12.1. Participant's Overview
    • 10.3.12.2. Financial Performance
    • 10.3.12.3. Product/Service Benchmarking
    • 10.3.12.4. Strategic Initiatives
  • 10.3.13. THOR Photomedicine Ltd
    • 10.3.13.1. Participant's Overview
    • 10.3.13.2. Financial Performance
    • 10.3.13.3. Product/Service Benchmarking
    • 10.3.13.4. Strategic Initiatives
  • 10.3.14. Equine & Canine Light Therapy
    • 10.3.14.1. Participant's Overview
    • 10.3.14.2. Financial Performance
    • 10.3.14.3. Product/Service Benchmarking
    • 10.3.14.4. Strategic Initiatives
  • 10.3.15. Mitoredlight
    • 10.3.15.1. Participant's Overview
    • 10.3.15.2. Financial Performance
    • 10.3.15.3. Product/Service Benchmarking
    • 10.3.15.4. Strategic Initiatives